The lack of updates and information is frustrating, but the current play on the table by rfp only looks encouraging. Why would they enter an jv agreement with AOW then try and take them over? The patient will be rewarded in my opinion
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025